or Try an Advanced Search...

    Monogenic Stocks List

    Symbol Grade Name % Change
    PASG C Passage Bio, Inc. 12.06
    RYTM D Rhythm Pharmaceuticals, Inc. -10.32
    SGMO F Sangamo BioSciences, Inc. 2.55
    TSHA D Taysha Gene Therapies, Inc. -5.34
    VYGR D Voyager Therapeutics, Inc. -1.90
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia

    Related ETFs - A few ETFs which own one or more of the above listed Monogenic stocks.

    Symbol Grade Name Weight
    BBP C BioShares Biotechnology Products Fund 1.89
    SBIO C ALPS Medical Breakthroughs ETF 1.59
    HELX D Franklin Genomic Advancements ETF 1.24
    XBI D SPDR S&P Biotech ETF 1.21
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.74
    View all Monogenic ETFs...
    Compare ETFs
    Compare BBP to HELX Compare BBP to LABD Compare SBIO to LABD

        Monogenic Stocks Recent News

        Date Stock Title
        May 7 TSHA Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14
        May 7 RYTM Rhythm Pharmaceuticals Reports Q1 2024 Results: Revenue Growth Amidst Challenges
        May 7 RYTM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Misses Revenue Estimates
        May 7 RYTM Rhythm Pharmaceuticals GAAP EPS of -$2.35 misses by $0.33, revenue of $25.97M misses by $0.93M
        May 7 RYTM Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
        May 6 VYGR Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns
        May 6 RYTM Rhythm Pharmaceuticals Q1 2024 Earnings Preview
        May 6 RYTM Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual Meeting
        May 6 VYGR Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
        May 3 VYGR Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
        May 2 SGMO Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
        May 2 SGMO Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
        May 2 VYGR Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
        May 2 TSHA Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
        May 2 TSHA Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
        May 1 RYTM Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Gene Therapy Huntington's Disease Life Sciences Lipid Storage Disorders Medicine Monogenic Diseases Organ Systems Rare Diseases Amyotrophic Lateral Sclerosis Ataxia Biopharmaceutical Blastoma Cell Product Central Nervous System Disorders Deficiency Deficiency Syndrome Dow Agrosciences Emerging Technologies Friedreich's Ataxia
        Monogenic

        Browse All Tags